Research

Limit: 2 // PIs:

Science & Engineering Track: Q. Hao (Aerospace & Mechanical Engineering)
Medical Research Track: M.  Kuhns (Immunobiology)

UA may submit one concept paper in Physical Sciences and Engineering and one concept paper in Medical Sciences in this cycle.
The selected projects must participate in the concept counseling session with the W.M. Keck Foundation between July 1 and August 15 to determine if they can proceed to the Phase I submission.

The W.M. Keck Foundation Research Program uses a three-step process for this opportunity. The first step is a Concept paper. The Undergraduate Education program is currently not accepting concept papers. The next steps are by the foundation’s invitation. UArizona review criteria reflect previous interactions with the W.M. Keck Foundation. Proposals should focus on basic, fundamental science with broad applications.

The proposed work should show a significant leap forward rather than an extension of existing work.  

To be considered by Keck, applicants must have a statement from a federal program officer expressing that the project is not a good fit due to risk (rather than technical or theoretical fit) or a decline from a federal program where the summary statement or individual reviews highlight the incredible novelty, but the high-risk nature that makes it difficult to fund at the federal level.

The Science and Engineering Research Program seeks to benefit humanity by supporting high-risk/high-impact projects that are distinctive and novel in their approach to intractable problems, push the edge of their field, or question the prevailing paradigm. Past grants have been awarded to support pioneering science and engineering research and the development of promising new technologies, instrumentation, or methodologies. 

The Medical Research Program seeks to advance the frontiers of medicine to benefit humanity by supporting high-risk/high-impact projects that are distinctive and novel in their approach to intractable problems, push the edge of their field, or question the prevailing paradigm. Past grants have supported pioneering biological research, basic research, and the development of promising new technologies. The Keck Foundation does NOT fund work that is clinical, applied, or translational; treatment trials; or research for the sole purpose of drug development. 

Both senior and early career investigators are encouraged to apply. Team approaches, including interdisciplinary teams, are encouraged.

Limit: Two applications per department*  // PIs: 
B. Wen (Child Health) 
M. Lee Frazure (Physiology)
A.Blythe C. (Asthma/Airway Disease Research Center)

*Each department may submit only two applications annually and is limited to a maximum of three active fellowships at any one time.

The Parker B. Francis Fellowship provides research support to clinical and basic scientists embarking on careers in clinical, laboratory or translational science related to Pulmonary, Critical Care and Sleep Medicine at a U.S. or Canadian university or research institution. The ideal candidate is one with evidence of strong aptitude in research and who is in transition from post-doctoral trainee to independent investigator. It is essential that there be evidence of accomplishment and proficiency in research. Few applicants who are just beginning research training and have only one or two research publications are funded. 

Applicants are eligible to apply for a PBF Fellowship if at the time of application they are:

1. Scientists holding a relevant doctoral degree (e.g., M.D., Ph.D., Sc.D., D.V.M., Dr. P.H.) who are embarking on a career in clinical, laboratory or translational science related to Pulmonary, Critical Care and Sleep Medicine at a U.S. or Canadian university or research institution.

2. A citizen or permanent resident of the U.S. or Canada or or holder of a Visa that spans the entire project period of the grant.

3. A Ph.D. or other non-M.D. scientist no more than seven years beyond completion of their doctoral degree or an M.D. scientist no more than seven years beyond clinical training (i.e., residency, internship, clinical fellowship) at the time of application. Candidates with greater than seven years since the doctoral degree require approval for continued training from the Scientific Director of the PBF Fellowship Program.

4. Applicants must be approved by their department to apply for the PBF Fellowship. Institutions may have no more than three Parker B. Francis Fellows in a single department at a given time, a department may submit nor more than two applications annually, and a mentor may sponsor only one application annually.

5. Individuals are not eligible for a PBF Fellowship if, at the time of application, they are or have been principal investigator on an NIH K or R series research award or other nationally competitive research award at the comparable level.

6. If a PBF Fellow receives an NIH K or Research Award or any nationally competitive grant at a similar level, at any point on or after the start date of the PBF award, the amount of the award will be changed per the Allowable Cost policy. Please contact PBF@thoracic.org for more information.

7. PBF Fellows are required to have at least 75 percent of their time available for research. Most successful candidates have two-to-five years of research experience and a minimum of two or three research publications at the time of fellowship application.

MENTORS
Mentorship of the fellow by an established investigator is required. Any established faculty scientist at a university or a not-for-profit research institution may mentor a candidate for fellowship. Mentors at government or corporate laboratories are not eligible. The mentor should be in a position to guarantee that 75 percent of a fellow's time is available for research. The mentor should be committed to fostering the candidate's career advancement and should be the primary scientific advisor. Secondary scientific mentors at the same or a different institution are encouraged but not required. Their roles should be described in the body of the application. Many fellows spend some portion of their fellowship years working with a secondary mentor, who is at another institution.

INSTITUTIONS
There are no restrictions regarding discipline or department. Clinical or basic science departments are suitable; however, it is expected that the proposed research will focus on lung biology or lung disease. Awards are limited to institutions located in the US and Canada, including medical schools, universities, major hospitals or other institutions affiliated with major universities. Each department may submit only two applications annually and is limited to a maximum of three active fellowships at any one time.

NOTES ABOUT OTHER GRANT SUPPORT
Individuals are not eligible for a PBF Fellowship if, at the time of application, they are or have been principal investigator on an NIH K or R series research award or other nationally competitive research award at a comparable level.

PBF Fellows in the second or third year of their Fellowship, who receive an NIH K or R series award or similar grant, may request approval to retain the Fellowship and to reallocate a portion of the Fellowship salary support to supplies or other research costs. In fact, obtaining research grants is an appropriate goal for PFB Fellows. Click here to learn more about the Allowable Cost Policy.

Awards will not be given if either the fellow or mentor currently holds funding from the tobacco industry, even if the tobacco monies will not be used to support the PBF sponsored research.

APPROPRIATE TOPICS
A broad array of approaches to pulmonary and critical care medicine, ranging from cell and molecular studies, to those involving epidemiologic and clinical aspects of human subjects are appropriate. We also encourage applications from pulmonary medicine specialists interested in pursuing research in bioethical aspects of pulmonary medicine or critical care. Potential topics include, but are not limited to, the ethics of clinical trials in critical care, end-of-life decisions and resource allocation. The context of all these topics should be pulmonary biology and lung disease. Applicants must meet all the eligibility standards. Mentors and/or applicants considering whether a particular area is appropriate are encouraged to discuss potential projects with the Scientific Director of the PBF Fellowship Program, Polly E. Parsons, M.D.

BUDGET

The Parker B. Francis Fellowship provides three years of funding. The budget year begins July 1 and ends June 30. The budget guidelines are included below.

The total budget for individuals starting a PBF Fellowship in 2022 is $225,000 over three years or $75,000 per year.

Allowable costs are restricted to the PBF Fellow’s salary plus fringe benefits and may include travel to a maximum of $2,000 per year. Any costs other than the Fellow’s salary support and travel allocation must be approved by the Scientific Director of the PBF Fellowship Program.

Direct research project costs should be supported by the mentor’s research grants. Such grants are an essential part of the application as documentation of sufficient financial support to complete the fellow’s project.

Indirect costs and equipment purchases are not allowed.

It is permissible to supplement a Parker B. Francis stipend with funds from research grants, departmental funds or clinical income (if clinical duties are minimal). If a supplement is accepted, an explanation regarding its source and subsequent obligations must be provided to the PBF Fellowship Program Office. Fellows are also encouraged to apply for additional grant support after receiving a PBF award.

If there is an unexpended balance at the end of the second fellowship year, the next year's award will be reduced by that amount. In the final year, any unexpended balance in excess of $1,000 must be returned to the Francis Family Foundation in Kansas City, Missouri.

No applicants // Limit: 1 // Tickets Available: 1 

An entity may submit only one Concept Paper and one Full Application to this FOA.

The research and development (R&D) activities to be funded under this FOA will support the government-wide approach to the climate crisis by driving the innovation that can lead to the deployment of clean energy technologies, which are critical for climate protection. Specifically, this FOA will invest in R&D to support continued innovation and cost reduction for high-voltage direct current (HVDC) voltage-source converter (VSC) transmission systems. This investment is intended to enable future grid upgrades required to integrate increasing renewable energy generation on to the grid, both onshore and offshore.EERE expects to make a total of approximately $10M of federal funding available for new awards under this FOA, subject to the availability of appropriated funds. EERE anticipates making approximately 3-4 awards under this FOA. EERE may issue one, multiple, or no awards. Individual awards may vary between $2.5M and $3.3M

Institutionally Coordinated // PIs: 
R. Goyal (Obstetrics and Gynecology)
A. Gallitano (Research Series - Basic Medical Sciences)
M. Cai (Chemistry and Biochemistry)
I.Gladysheva (Research Series - Internal Medicine)
G.Gurtner (Surgery)
S.Goldman (Cardiology)
Z.Li (Orthopaedic Research)
P. Govindappa (Orthopaedic Surgery)
M. Ahmed (Neonatology)
A. Avellino (Pediatric Neurosurgery)
C. Curiel-Lewandrowski (Dermatology)
E. Erickson (Nursing)/ S. Aras (Sensor Analysis & Smart Platforms)
H.Li (Pharmacology and Toxicology)
M. Johnson (Immunobiology)
J. Lacombe (Research Series - Basic Medical Sciences)
R. Liang (Optical Sciences)
E. Enikov (Aerospace and Mechanical Engineering)
C.Hulme (Chemistry and Biochemistry)

Submissions will require an institutional letter of support. Because of this support requirement, this is an Institutionally Coordinated Submission. 

The Flinn Foundation’s 2023 Seed Grants to Promote Translational Research Program will fund up to 10 research teams focused on advancing new products or services to improve patient care. The teams must be affiliated with Arizona’s academic research institutions and/or health-care systems.

The awardees will each receive a $100,000 grant over 18 months. At the end of the grant period, up to two of the most successful projects may receive up to an additional $100,000 over the following year.

The proposed projects must address compelling clinical needs in the areas of precision medicine, diagnostics, devices, therapeutics, or health-care-delivery processes and have significant potential to turn bench results into viable products or systems impacting patients in Arizona and beyond.

Limit: 1  // PI: V. Kamath (Basic Medical Sciences)

The objective of the BRF Seed Grant Program is to support new and innovative projects, especially those of junior faculty, who are working in new research directions.To be eligible, PI must be a full-time Assistant or Associate Professor working in the area of studies of brain function. This includes molecular and clinical neuroscience as well as studies of neural, sensory, motor, cognitive, behavioral and emotional functioning in health and disease. Each total grant is limited to $80,000 (direct costs) for a two year grant period. Funding is to be directed at pilot research projects that are both innovative and will likely lead to successful grant applications to NIH and other public and private funding entities.

Eligibility
To be eligible, PI must be a full-time Assistant or Associate Professor at an invited US academic institution, working in the area of studies of brain function. This includes molecular and clinical neuroscience as well as studies of neural, sensory, motor, cognitive, behavioral and emotional functioning in health and disease. The grant proposal must detail a new research project that is not funded by other sources. This grant is not to be used as bridge funding.

Investigators at institutions that are affiliated with a medical school or university are eligible to apply only through the institution where they hold a full-time faculty position.

Scientists that have previously received a BRF Seed Grant may not receive the award for a second time unless all grant requirements from all previous awards are met. Only one PI may apply per application.

Limit: 2  // PIs: 
Kenry (Pharmaceutics & Pharmacokinetics)
S. Song (Biomedical Engineering)

Only two nominations are allowed per institution.

These competitive research awards provide seed money for junior faculty members that often result in additional funding from other sources. The award amount provided by ORAU is $5,000. The applicant’s institution is required to match the award with at least an additional $5,000. This is a one-year grant (June 1 to May 31).

Eligibility for the Powe Awards is open to full-time assistant professors at ORAU member institutions within two years of their tenure track appointment at the time of application. If there is a question about eligibility, your ORAU Councilor makes the final determination. Only two nominations are allowed per institution.

Research projects must fall within one of these five disciplines:

• Engineering and Applied Science
• Life Sciences
• Mathematics/Computer Sciences
• Physical Sciences
• Policy, Management, or Education

Junior faculty members interested in applying should consult their ORAU Councilor, and visit the frequently asked questions.

 The University of Arizona Cancer Center (UACC) coordinates the selection process for this limited submission opportunity. For more information, please contact: UACC-PreAward@arizona.edu 

UACC Limited Submission Information:

The University of Arizona Cancer Center (UACC) can nominate one application for the NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) for FY2024.

Purpose of Award:

The UACC is seeking nominations for an NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) which is to encourage and retain outstanding graduate students recognized by their institutions for their high potential and strong interest in pursuing careers as independent cancer researchers. The award will facilitate the transition of talented graduate students into successful cancer research postdoctoral appointments and provide opportunities for career development activities relevant to their long-term career goals of becoming independent cancer researchers.

This Notice of Funding Opportunity (NOFO) does not allow applicants to propose to lead an independent clinical trial, but does allow applicants to propose research experience in a clinical trial led by a sponsor or co-sponsor.

Applicant Eligibility:

• Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with their organization to develop an application for support. Individuals from diverse backgrounds, including underrepresented racial and ethnic groups, individuals with disabilities, and women are always encouraged to apply for NIH support.
• An applicant must be a citizen or a noncitizen national of the United States, or has been lawfully admitted for permanent residence (i.e., possess a currently valid Permanent Resident Card USCIS Form I-551, or other legal verification of such status), or be a non-U.S. citizen with a valid U.S. visa. For applications submitted on behalf of non-U.S. citizens with valid U.S. visas, the visa status during each phase of the F99/K00 award must allow the PD/PI to conduct the proposed research at the applicant institution. For the F99 phase of the award, the applicant F99 institution is responsible for determining and documenting, in the nomination letter, that the applicant's visa will allow the applicant to remain in the U.S. to complete the F99 phase of the award, and that there are no known obstacles that would prevent the applicant from obtaining a visa for the K00 phase. For the K00 phase of the award, the U.S institution at which the K00 phase of the award will be conducted is responsible for determining and documenting, in the transition application, that the PD/PI’s visa will allow the PD/PI to remain in the U.S. for the duration of the K00 award. NCI may request verifying information as part of the pre-award process.
• The applicant must have a baccalaureate degree and be currently enrolled as a graduate student in the third or fourth year of a mentored PhD or equivalent research degree program (e.g., DrPH, ScD) in the biomedical, behavioral, or clinical sciences at a domestic institution. F99 eligibility is determined from the date of enrollment as a graduate student at the PhD institution and includes the time spent to earn a MS degree unless there was a major change in research area and a change in research mentor. The applicant must be at the dissertation research stage of training at the time of award, and must show evidence of high academic performance in the sciences and commitment to a career as an independent cancer research scientist.
• This program is expected to enhance the research career trajectories of cancer researchers and foster progression to research independence. K00 awardees remain eligible to apply to subsequent mentored Career Development (K) and Pathway to Independence (K99/R00) award programs.
• The F99/K00 award may not be used to support studies leading to the MD, DDS, or other clinical, health-professional degree (e.g., DC, DMD, DNP, DO, DPM, DVM, ND, OD, AuD). Students matriculated in a dual-degree program (e.g. MD/PhD, DO/PhD, DDS/PhD, or DVM/PhD) are not eligible for the F99/K00 program.

N. Kitamura on behafh J.Galligan's Lab (Pharmacology and Toxicology)
K. Rahman on behafh H. Li's Lab (Pharmacology and Toxicology)

Only one postdoctoral applicant per lab may apply for this award.

Successful drug discovery involves the innovative application and integration of multiple scientific disciplines to create efficacious, safe, and differentiated treatment options for patients. The PhRMA Foundation seeks to fund novel early-stage, exploratory drug discovery research with the potential for translation to humans, including biological validation of potential drug targets, signaling pathways, or mechanisms of disease.  

Research topics could include, but are not limited to:   

• Genomics and Proteomics  
• Cellular and Molecular Biology  
• Design and Generation of Pharmacological Tools   
• In Vitro and/or In Vivo Pharmacology  
• Protein Biochemistry  
• Molecular Modelling  
• Structural Biology  
• Cell Imaging  
• Single Cell Analysis  
• Artificial Intelligence and Computational Approaches  

Projects that focus exclusively on single aspects such as identification of and development of assays for single targets, chemical probes, biomarkers, chemical library screening, or diagnostics will not be considered for review. Project aims should have a high likelihood of completion in the award timeframe

No applicants  // Limit: 1 // Tickets Available: 1 

This Funding Opportunity Announcement (FOA) is designed to support highly integrated research teams of three to six Program Directors/Principal Investigators (PDs/PIs) to address ambitious and challenging research questions that are within the mission of NIGMS. Project goals should not be achievable with a collection of individual efforts or projects. Collaborative program teams are expected to accomplish goals that require considerable synergy and managed team interactions. Teams are encouraged to consider far-reaching objectives that will produce major advances in their fields.

This FOA is not intended for applications that are mainly focused on the creation, expansion, and/or maintenance of community resources, creation of new technologies, or infrastructure development.

Limit: 2  // PIs: 
H. W .Tseng (College of Medicine Tucson -Medical Imaging) 
X. Yan (Materials Science) 

The Moore Inventor Fellows fellowship focuses on supporting scientist-inventors at a critical prototyping stage to capture opportunities that otherwise might be missed. We seek to provide freedom and support to promising inventors with the most compelling ideas to pursue creative and disruptive innovations.

The scope of this call is intentionally wide: proposed projects do not need to fall within our current funding priorities but should be broadly within the program areas of foundation interest (science, environmental conservation and patient care). Patient care inventions should resonate with our focus on improving the experience and outcomes of patients with solutions that improve clinical diagnosis.

Eligibility: Candidates must be faculty, research scientists, postdocs or other full-time staff who can receive funding through their institutions. Candidates must be no more than 10 years past receiving their terminal advanced degree in their field (M.S., Ph.D. or M.D.) Please see the Moore Inventor Fellows FAQ for more information regarding candidate eligibility and exceptions.

Funding: Fellows will receive funding for three years at a level of $200,000 per year from the Moore Foundation. In addition to funds for the fellow, the foundation will provide $25,000 each year to the institution to cover costs associated with administering the grant award, resulting in a total three-year award of $675,000. Host institutions are required to contribute $50,000 in annual support of the inventor’s work